Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT

Bilimoria, 2009, Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base, Dis Colon Rectum, 52, 624, 10.1007/DCR.0b013e31819eb7f0 Johnson, 2004, Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973–2000, Cancer, 101, 281, 10.1002/cncr.20364 Glynne-Jones, 2016, Squamous-cell carcinoma of the anus: Progress in radiotherapy treatment, Nat Rev Clin Oncol, 10.1038/nrclinonc.2015.218 Ajani, 2008, Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal, JAMA, 299, 1914, 10.1001/jama.299.16.1914 Bartelink, 1997, Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastro, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040 Witkowska, 2015, The role of radiotherapy in Hodgkin’s lymphoma: What has been achieved during the last 50 years?, Biomed Res Int, 2015, 10.1155/2015/485071 Lardinois, 2003, Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N Engl J Med, 348, 2500, 10.1056/NEJMoa022136 Mehanna, 2016, PET-CT surveillance versus neck dissection in advanced head and neck cancer, N Engl J Med, 374, 1444, 10.1056/NEJMoa1514493 Pfannenberg, 2019, Practice-based evidence for the clinical benefit of PET/CT—results of the first oncologic PET/CT registry in Germany, Eur J Nucl Med Mol Imaging, 46, 54, 10.1007/s00259-018-4156-3 Rice, 2020, The utility of PET/computed tomography for radiation oncology planning, surveillance, and prognosis prediction of gastrointestinal tumors, PET Clinics, 15, 77, 10.1016/j.cpet.2019.08.004 Dapper, 2019, Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines, BMC Cancer, 19, 1, 10.1186/s12885-019-5970-0 Deantonio, 2016, Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival, Radiol Med, 10.1007/s11547-015-0562-9 Cardenas, 2017, Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus, Adv Radiat Oncol, 10.1016/j.adro.2017.04.007 De Winton, 2009, The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, Br J Cancer, 100, 693, 10.1038/sj.bjc.6604897 Oncology, R. Elective Clinical Target Volumes in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas. Vanderhoek, 2013, Impact of different standardized uptake value measures on PET-based quantification of treatment response, J Nucl Med, 10.2967/jnumed.112.113332 Larson, 1999, Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis, Clin Positron Imaging, 10.1016/S1095-0397(99)00016-3 Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X Martin, 2019, Chemoradiotherapy for anal cancer : are we as good as we think, ? James, 2013, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2×2 factorial trial, Lancet Oncol, 10.1016/S1470-2045(13)70086-X Jones, 2015, The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis, Ann Surg Oncol, 22, 3574, 10.1245/s10434-015-4391-9 Nguyen, 2008, Assessing the impact of FDG-PET in the management of anal cancer, Radiother Oncol, 87, 376, 10.1016/j.radonc.2008.04.003 Hofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study, Lancet, 10.1016/S0140-6736(20)30314-7 Grigsby, 2009, FDG-PET/CT: New horizons in anal cancer, Gastroenterol Clin Biol, 33, 456, 10.1016/j.gcb.2009.01.012 Trautmann, 2005, Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal, Mol Imaging Biol, 7, 309, 10.1007/s11307-005-0003-6 Kidd, 2010, Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis, Radiother Oncol, 10.1016/j.radonc.2010.02.019 Gauthé, 2017, Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer, Eur J Nucl Med Mol Imaging, 10.1007/s00259-016-3475-5 Jones, 2019, FDG-PET parameters predict for recurrence in anal cancer - Results from a prospective, multicentre clinical trial, Radiat Oncol, 10.1186/s13014-019-1342-9 Bazan, 2013, Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal, J Nucl Med, 54, 27, 10.2967/jnumed.112.109470 Mohammadkhani Shali, 2016, Metabolic tumour volume of anal carcinoma on18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival, Eur J Radiol, 10.1016/j.ejrad.2016.05.009 Lambrecht, 2012, Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results, Int J Radiat Oncol Biol Phys, 82, 863, 10.1016/j.ijrobp.2010.12.063 Borggreve, 2019, Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer, Eur Radiol Barbour, 2020, Ann Oncol Jones, 2020, A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma, Radiother Oncol, 10.1016/j.radonc.2019.10.001 Goldman, 2016, Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma, Pract Radiat Oncol, 6, e149, 10.1016/j.prro.2016.01.004 A Mahmud, R Poon, D Jonker, SySteMAtiC Review Pet imaging in anal canal cancer: a systematic review and meta-analysis 1; 2017. Zimmermann, 2017, PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer, Acta Oncol (Madr), 56, 1734, 10.1080/0284186X.2017.1325003